Table 3 Response to pneumococcal vaccination in the overall cohort
Pneumococcal serotype | Serum samples | Anti-CP GMC†(95% CI) (µg/mL) | Mean fold rise (95% CI) |
|---|---|---|---|
6B | Baseline | 0.54 (0.21–1.38) | – |
Post-vaccination | 2.13 (0.72–6.28)** | 3.96 (1.70–9.22) | |
9V | Baseline | 1.19 (0.64–2.22) | – |
Post-vaccination | 4.25 (2.19–8.24)*** | 3.57 (1.84–6.93) | |
19A | Baseline | 7.78 (4.2–14.4) | – |
Post-vaccination | 15.34 (8.39–28.05)** | 1.97 (1.26–3.09) | |
19F | Baseline | 1.70 (0.64–4.56) | – |
Post-vaccination | 7.76 (3.26–18.46)*** | 4.56 (2.26–9.21) | |
23F | Baseline | 0.94 (0.43–2.08) | – |
Post-vaccination | 3.81 (1.56–9.30)**** | 4.03 (2.35–6.92) |